Tag Archives: vaccine development

Abrysvo RSV Vaccine Shows Promise for At-Risk Adults: Phase 3 Trial Results

Pfizer's Abrysvo RSV vaccine shows promise in a phase 3 trial for at-risk adults aged.....Read more

Unmet Needs in RSV Prevention and Management

RSV prevention and management face ongoing challenges, especially for infants lacking accessible preventative options. Continued.....Read more

RSV: New Tools and Treatments Offer Hope in Europe

Respiratory syncytial virus (RSV) poses a significant health threat, particularly to vulnerable populations. Recent advancements.....Read more